Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
galdestensopløsningsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Product containing ursodeoxycholic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
ursodiol 250 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodeoxycholic acid (substance) |
Is a |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Ursodiol |
Is a |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Chenodeoxycholic acid (substance) |
Is a |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|
Dehydrocholic acid (substance) |
Is a |
False |
galdestensopløsningsmiddel |
Inferred relationship |
Some |
|